|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate owned: | ||||||||||||||||||||
| Real estate held for investment | ||||||||||||||||||||
| Less: accumulated depreciation | ||||||||||||||||||||
| Real estate held for investment, net | ||||||||||||||||||||
| Real estate under development (net of accumulated depreciation of $0 and $0, respectively) | ||||||||||||||||||||
| Real estate held for disposition (net of accumulated depreciation of $79,664 and $0, respectively) | ||||||||||||||||||||
| Total real estate owned, net of accumulated depreciation | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Notes receivable, net | ||||||||||||||||||||
| Investment in and advances to unconsolidated joint ventures, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Secured debt, net | ||||||||||||||||||||
| Unsecured debt, net | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Real estate taxes payable | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Security deposits and prepaid rent | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Accounts payable, accrued expenses, and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests in the Operating Partnership and DownREIT Partnership | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock, no par value; 50,000,000 shares authorized at June 30, 2026 and December 31, 2025: 8.00% Series E Cumulative Convertible; 2,600,678 and 2,600,678 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively, Series F; 9,778,769 and 10,105,845 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| 8.00% Series E Cumulative Convertible Preferred Stock | ||||||||||||||||||||
| Series F | ||||||||||||||||||||
| Common stock, $0.01 par value; 450,000,000 shares authorized at June 30, 2026 and December 31, 2025: 321,266,356 and 328,273,044 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Distributions in excess of net income | ||||||||||||||||||||
| Accumulated other comprehensive income/(loss), net | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
